People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Concerto Biosciences, Inc. | — | Biotechnology | Series B | $24.5M | $472.6M | 2022 |
| 2Pi Inc. | — | Other Technology | Series A | $11.7M | $38.7M | 2025 |
| Active Surfaces Inc. | — | Other Technology | Seed | $4.9M | $4.3M | 2025 |
Vera Schroeder at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Vera Schroeder on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Reed Sturtevant | 1 | 8 |
| Juejun Hu | 1 | 1 |
| Tian Gu | 1 | 1 |
| Shivam Bhakta | 1 | 1 |
| Richard Swartwout | 1 | 1 |
| Sarah Luppino | 1 | 1 |
| Jared Kehe | 1 | 1 |
| Cheri Ackerman | 1 | 1 |
| Bernardo Cervantes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.